In episode 4, Dr. Atul Verma, Director of the Heart Rhythm Program at Southlake Regional Health Centre and associate professor at University of Toronto discusses managing atrial fibrillation in diabetes care. As patients with diabetes are at risk of developing atrial fibrillation, Dr. Verma gives us insights on the use of novel oral anticoagulants (NOACs). He discusses the potential benefit of this treatment method such as reducing adverse effects including major limb events and the potentially preserving renal function. For patients with diabetes, what is the likelihood they develop atrial fibrillation? Listen to find out. The answer may surprise you! This program was made possible through funding from Bayer.